Zygote Intrafallopian Transfer

Zygote Intrafallopian Transfer (ZIFT) is an assisted reproductive technology (ART) procedure that is used to treat infertility in women. During ZIFT, a single or multiple eggs are removed from the woman's ovaries and placed in a special medium in a laboratory. The eggs are then fertilized with the sperm from her partner or a donor in the laboratory. Once the eggs are fertilized, they are then placed back into the woman's fallopian tubes. The fertilized eggs are then allowed to travel naturally into the uterus where they can implant and develop into a healthy pregnancy. The success rate of ZIFT is approximately 60-70%, which is higher than traditional in-vitro fertilization (IVF). ZIFT is a more natural process, as the eggs are able to travel to the uterus and are not exposed to the harsh environment of the laboratory. The preparation for the procedure is similar to that of IVF, with the woman taking fertility drugs and having the eggs retrieved from her ovaries. After the eggs are retrieved, they are placed in a special medium. The eggs are then injected with a single sperm or multiple sperm using a specialized pipette. The eggs are placed back into the woman's fallopian tubes, where they will naturally travel to the uterus. ZIFT is a good option for women who are experiencing infertility due to blocked or damaged fallopian tubes or for couples who have had multiple failed IVF cycles. It is also an option for women who have had a history of miscarriages or who are at a higher risk of developing a chromosomal abnormality. Overall, Zygote Intrafallopian Transfer is a safe and effective procedure that can help couples achieve their goal of having a baby.